Pharmaceuticals

Global Pharmaceutical Contract Manufacturing Market (Drug Type and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020

  • ALL22988
  • 0 Pages
  • November 1999
  • Pharmaceuticals

The global market for pharmaceutical contract manufacturing represents one of the fastest growing markets and it is expected to proffer enormous opportunities in the near future. Contract manufacturing contributes significantly to the overall outsourcing market, owing to its popularity and widespread adoption by pharmaceutical companies. Cost containment issues resulted from global economic constraints, have exerted extensive pressure on pharmaceutical manufacturers to reduce the cost of products. Hence, to make way out of this situation, pharma companies are looking to reduce the manufacturing cost. Contract manufacturing, as a strategic option, offers the certain benefits such as cost reduction, improved product quality, product portfolio and reduction in time to market. Contract manufacturing also support the pharmaceutical companies to focus on R&D and marketing activities by minimizing the time and efforts invested in manufacturing activity. Hence, contract manufacturing is the largely accepted trend in the recent years. HAUPT Pharma AG, Abbott Laboratories, NextPharma, Catalent Pharma Solutions, Althea Technologies, Jubilant Life Sciences Limited, Royal DSM N.V and Nipro Corp. are some of the big players of this market. Patent expiration of major therapeutic brands, growing demand for generic drugs and adoption of novel manufacturing technologies are expected to boost the growth of this market.

The global market for pharmaceutical contract manufacturing is segmented based on type of contract manufacturing and geography. Based on type of contract manufacturing, the market is segmented as, Active Pharmaceutical Ingredients (API) / Bulk drug, Final Dosage Form (FDF), advanced drug delivery products, OTC medicines and Nutritional products and     Packaging contract manufacturing. The final dosage form contract manufacturing (FDF) is expected to grow with substantial CAGR due to growing demand for generic products and rising R&D investments. Geographically, global market for pharmaceutical contract manufacturing is segmented into North America, Europe, Asia-Pacific and LAMEA. North America dominates the global contract manufacturing market, whereas, Asia-Pacific is the fastest growing market due to adoption of advanced technologies, favorable regulatory framework, reduced labor cost and availability of skilled workforce.

KEY BENEFITS

This report offers the following benefits in particular:

  • In-depth coverage of drivers, restraints and opportunities within global market for pharmaceutical contract manufacturing would help professionals to better understand market behavior
  • Porter’s Five Forces analysis examines the competitive structure of the global market for pharmaceutical contract manufacturing and would assist market strategists in their respective decision making process
  • Pin-point analysis of geographic segments helps to identify opportunities for growth within the global market for pharmaceutical contract manufacturing
  • Deep insights on key developments and regulatory framework of global market for pharmaceutical contract manufacturing would be informative for professionals in corporate sector  

KEY MARKET SEGMENTS

The global market for pharmaceutical contract manufacturing is segmented into two major categories such as, type and geography. 

MARKET BY DRUG TYPE

  • Active Pharmaceutical Ingredients (API) / Bulk drug 
  • Final Dosage Form (FDF) 
    • Solid dosage form
    • Semi-solid dosage form
    • Liquid dosage form
  • Advanced drug delivery products 
  • OTC medicines and Nutritional products
  • Packaging

MARKET BY GEOGRAPHY

  • North America
  • Europe
  • Asia-Pacific
  • LAMEA
Please Select Format

Enquiry About Report

Need More Information

Contact us
+ 1-800-910-6452
+1-971-202-1575
+91 20 66346066
--- or ---
help@bigmarketresearch.com

 

UPCOMING MARKET RESEARCH REPORTS

Global General Medicine Education Publishing Market (Type, Geography) Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Opportunities, Segmentation, Forecast (2013-2020)

General medicine is a branch of medicine that deals with diagnosis and treatment of diseases associated with internal organs. It is also called as Internal Medicine. General medicine education market has shown substantial growth due to the adoption of internal medicine as a career option by medical students.

July 2017 | $5370 | Pre Book Price:$4699

Cancer Vaccine Market Global Scenario, Market Size, Outlook, Trend and Forecast, 2015- 2024

Cancer vaccines are biological response modifiers. These vaccines work by stimulating or restoring the immune system�s ability to fight against infections and diseases. It is used either as stand-alone therapies ...

July 2017 | $4995 | Pre Book Price:$4371

World Active Pharmaceutical Ingredient (API) Market - Opportunities and Forecasts, 2014 - 2020

Increase in Abbreviated New Drug Applications (ANDA) over the past years has fostered the demand for API market. Furthermore, Indian companies making increased entries related to Drug Master File (DMF) ...

July 2017 | $5370 | Pre Book Price:$4699

Anterior Uveitis Asia-Pacific Market Research Report, 2014 - 2020

Anterior uveitis is an eye inflammation that involves middle layer of the eye specifically, iris (colored part of the eye) and ciliary body (adjacent tissue). Untreated anterior uveitis results in ...

July 2017 | $2850 | Pre Book Price:$2494

Nanomedicine Asia-Pacific Market Research Report, 2014 - 2020

Nanomedicine is the applied branch of nanotechnology. Application of nanomedicines ranges from nonmaterial to nanoelectronic and in the near future, it could possibly expand to molecular nanotechnology. Biological, pharmaceutical and ...

July 2017 | $2850 | Pre Book Price:$2494

Autoimmune Disorders Treatment Asia-Pacific Market Research Report, 2014 - 2020

Graves disease, Multiple sclerosis, Myasthenia gravis, Rheumatoid arthritis, Pernicious anemia and Systemic lupus erythematosus are the most prevalent types of autoimmune disorders. The prevalence of autoimmune diseases is high in ...

July 2017 | $2850 | Pre Book Price:$2494

2017 © Copyright Big Market Research

View Pricing >>